4//SEC Filing
CELGENE CORP /DE/ 4
Accession 0001209191-15-043354
CIK 0000816284operating
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:30 PM ET
Size
9.1 KB
Accession
0001209191-15-043354
Insider Transaction Report
Form 4
STEIN LAWRENCE V
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2015-05-14$39.33/sh+2,542$99,977→ 16,591 total - Sale
Common Stock
2015-05-14$114.85/sh−2,542$291,949→ 14,049 total - Exercise/Conversion
Stock Option (right to buy)
2015-05-14−2,542→ 5,084 totalExercise: $39.33Exp: 2022-12-03→ Common Stock (2,542 underlying)
Holdings
- 519(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The option was fully exercisable.
- [F2]The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (amended and restated as of April 17, 2013).
Documents
Issuer
CELGENE CORP /DE/
CIK 0000816284
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000816284
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:30 PM ET
- Size
- 9.1 KB